Brian Cox shares story at his old school to inspire others
Prof Cox, who co-hosts The Infinite Monkey Cage on BBC Radio 4 and presented the Wonders Of series on TV, also took part in a question and answer session with students from 17 schools and colleges at Oldham Sixth Form College."He spoke about so many amazing things in such detail, It was really fascinating to hear about so many scientific concepts," one audience member said.Another student said they definitely thought they now wanted to get into science because "it sounded a lot more interesting when he spoke about it", adding: "He made me feel like there's more to science."Another audience member said Prof Cox had been "inspiring".The visit was part of the Great Horizons events, an initiative to ignite ambition in science, technology, engineering and maths across Oldham. Prof Cox told the crowd: "You can be what you want to be and there are lots of jobs available in the economy of the future."
Listen to the best of BBC Radio Manchester on Sounds and follow BBC Manchester on Facebook, X, and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Mother of two becomes the first UK patient to receive ‘groundbreaking' new diabetes drug
A mother of two has become the first adult in the UK to try a 'groundbreaking' drug which can delay the need for insulin in diabetes patients. Hannah Robinson, a 36-year-old dentist, is being treated with teplizumab at Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1 diabetes. A handful of people are also being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. With type 1 diabetes, the immune system attacks insulin -producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body and people with the condition, therefore, need daily insulin. If blood sugar is too high or too low, it can cause serious health problems and even death. Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average three years. Ms Robinson said: 'For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin. This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition. This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this.' Teplizumab must be given at the earliest stage of the disease to be effective. Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: 'This new treatment represents a really exciting shift in how we manage type 1 diabetes. For the first time ever, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin. Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment. My hope is that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all.' Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes. The hope is that more people could be offered the drug to delay type 1. Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: 'For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free. 'Right now, it's only available in research settings – and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit. That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale. 'Diabetes UK is proud to be at the forefront of these efforts – funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment for tackling the autoimmune attack at the root of type 1 diabetes.'
Daily Mail
an hour ago
- Daily Mail
Harry Potter's new Hogwarts Express revealed after it nearly ended up on the scrap heap
More than 40 years ago the Wightwick Hall steam locomotive was saved from a scrapyard. Now it is on track for worldwide fame as it has been selected to feature as the Hogwarts Express in the upcoming Harry Potter TV series. The locomotive, which has been beautifully restored over 41 years by volunteers, will transport the wizard from platform 93⁄4 at London's King's Cross station to the school of magic. The Wightwick Hall was built in 1948. It travelled 640,000 miles with the Great Western Railway before being withdrawn in 1964 and sold to a scrapyard in Barry, South Wales. In 1978 it was bought for £9,180 byvolunteers from Buckinghamshire Railway Centre in Quainton who restored it. The loco is now on long-term loan to the Bluebell Railway in West Sussex. The Wightwick Hall will spend six months a year filming for the HBO series for the next eight years. It will run at the tourist attraction in between shoots. Filming for the latest adaptation of JK Rowling's novels will begin this month and the show is due to air next year. Dominic McLaughlin, 11, has landed the role of Harry Potter while Arabella Stanton, 11, will play Hermione Granger and Alastair Stout, 11, will star as Ron Weasley. In the films, released between 2001 and 2011, the Olton Hall engine – now at the Warner Bros Studio Tour near Watford – starred as the Hogwarts Express. Last month JK Rowling revealed her involvement in writing scripts for the upcoming TV series, after online trolls demanded she be removed over her views on transgender issues. The author, 59, who created the fantasy novels on which the show is based, took to X to rave about the first two episodes after reading them for the first time, confirmed that while she did not pen them herself, she did work closely with the writers. She said: 'I read the first two episodes of the forthcoming HBO Harry Potter series and they are SO, SO, SO GOOD!'. When one follower enquired: 'So you are not doing the writing for the show?' she replied: 'No, but I've worked closely with the extremely talented writers'. Last year HBO defended Rowling after being inundated with complaints about her serving as an executive producer on the new series. In a statement to Variety, HBO said: 'We are proud to once again tell the story of Harry Potter – the heartwarming books that speak to the power of friendship, resolve and acceptance. 'JK Rowling has a right to express her personal views. We will remain focused on the development of the new series, which will only benefit from her involvement.' The decision to adapt Rowling's novels has faced criticism from numerous fans, with many calling another adaptation 'unnecessary.' Others have stated they plan to boycott the project due to the author's comments on trans people. Earlier this month actor Nick Frost revealed he'd been targeted by trans activists after accepting the role of Hagrid. The actor, 53, will star as the legendary Hogwarts groundskeeper in the much-anticipated show, which is set to begin filming this summer. However after sharing the exciting announcement on Instagram, Nick revealed he was forced to turn off the comments on the post due to being swamped with criticism for collaborating with Rowling. Distancing himself from her trans views, Nick told the Observer: 'She's allowed her opinion and I'm allowed mine. They just don't align in any way, shape of form.'
The Independent
8 hours ago
- The Independent
New research suggests women in midlife can benefit from ‘gym bro' supplement
Until recently, creatine supplements was almost exclusively used by athletes and bodybuilders looking to enhance performance and pack on muscle mass. But now there is a surprising rapidly growing market for it: middle aged women. While Dwayne 'The Rock' Johnson still puts in his protein shake to 'put on size,' Ivanka Trump revealed earlier this year she takes a dose with her morning smoothie. From fitness influencers on TikTok to health experts, the chalky powder is now being touted for a range of benefits for women. So, what exactly is creatine and does the science back up the hype? 'Creatine is a natural compound that comes from three amino acids – arginine, glycine, and methionine,' Dr. Rupa Parmar, a physician and Director at Midland Health, tells The Independent. 'It's stored mainly in our muscles to help produce energy.' While small amounts come from foods like red meat and fish, our bodies also make about a gram each day. Most women don't get the recommended three to five grams per day from food, Rupar said, and supplementation may help. 'Women naturally have much lower creatine stores than men and usually eat less of it in their diet, so they may actually benefit more from taking creatine to boost their levels,' he added. Creatine's rise as a go-to supplement can be traced to 1992 when British sprinter Linford Christie and hurdler Sally Gunnell, both vocal about its use, won gold at the Barcelona Olympics. Glossy fitness magazines began branding it a 'breakthrough'; a 1998 article in Fortune magazine called the compound 'nature's steroid'; a Los Angeles Times headline blared, 'Power powder.' While much of its early reputation focused on muscle-building and workout recovery, research suggests creatine's benefits may extend beyond the gym. Creatine has been linked to improved memory, brain health, depression treatment and increased energy. 'It can even support brain health, with studies suggesting the substance helps to improve cognitive function and provide some protection as we age,' Rupar said. A preliminary study by the University of Kansas Medical Center on people with Alzheimer's found that creatine supplements may improve memory and executive function. Creatine may also offer benefits tied to hormonal fluctuations. 'Creatine can help ease fatigue during your period by supporting stable energy levels,' Rupar continued, 'especially when you're feeling more tired.' Oestrogen and progesterone, hormones that regulate the menstrual cycle, influence how the body produces and uses creatine, he explained. 'During the menstrual cycle, creatine levels can change, and supplements may help keep energy and muscle function more stable, especially when oestrogen is low,' Rupar said. For women approaching or going through menopause, creatine appears especially promising as it may help counteract declines in muscle mass, strength, and bone density, particularly when combined with resistance training. One 12-month study found that creatine reduced the loss of bone mineral density in 47 postmenopausal women. For all its potential upsides, creatine isn't without drawbacks. One of the most common complaints is bloating: because it saturates the muscles, it may cause water retention, which sometimes leads to a bloated feeling and a few extra pounds on the scale from water weight. Still, studies have repeatedly shown creatine to be safe for most healthy adults when taken at recommended doses. Experts advise consulting a healthcare provider before starting, especially for those with kidney conditions or who are on medication.
